Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
23M
-
Shares change
-
+1.31M
-
Total reported value, excl. options
-
$1.45B
-
Value change
-
+$109M
-
Put/Call ratio
-
1.96
-
Number of buys
-
98
-
Number of sells
-
-59
-
Price
-
$62.86
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2019
178 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q4 2019.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23M shares
of 53M outstanding shares and own 43.38% of the company stock.
Largest 10 shareholders include FMR LLC (3.86M shares), CAS Investment Partners, LLC (2.82M shares), WELLINGTON MANAGEMENT GROUP LLP (1.69M shares), BlackRock Inc. (1.17M shares), VANGUARD GROUP INC (1.04M shares), Antipodean Advisors LLC (656K shares), 683 Capital Management, LLC (575K shares), Grantham, Mayo, Van Otterloo & Co. LLC (517K shares), JENNISON ASSOCIATES LLC (482K shares), and TIGER GLOBAL MANAGEMENT LLC (455K shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.